Ann Neurol. 1992;32 Suppl:S101-4.

Distribution of iron in different brain regions and subcellular compartments in Parkinson's disease.

Riederer P, Dirr A, Goetz M, Sofic E, Jellinger K, Youdim MB.

Source

Department of Psychiatry, Clinical Neurochemistry, University of Würzburg, Germany.

PMID:: 1510366; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Review

MeSH Terms

Substances

Iron

LinkOut - more resources

Medical

Molecular Biology Databases

IRON - HSDB

Supplemental Content

Save items

Related citations in PubMed

Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease. [J Neurochem. 1989]
Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease.
Dexter DT, Wells FR, Lees AJ, Agid F, Agid Y, Jenner P, Marsden CD. J Neurochem. 1989 Jun; 52(6):1830-6.
Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis. [J Neurochem. 1991]
Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis.
Hirsch EC, Brandel JP, Galle P, Javoy-Agid F, Agid Y. J Neurochem. 1991 Feb; 56(2):446-51.
Altered systemic iron metabolism in Parkinson's disease. [Neurology. 1997]
Altered systemic iron metabolism in Parkinson's disease.
Logroscino G, Marder K, Graziano J, Freyer G, Slavkovich V, LoIacono N, Cote L, Mayeux R. Neurology. 1997 Sep; 49(3):714-7.
Review The neuropsychiatry of brain iron. [J Neuropsychiatry Clin Neurosc...]
Review The neuropsychiatry of brain iron.
Sachdev P. J Neuropsychiatry Clin Neurosci. 1993 Winter; 5(1):18-29.
Review The potential role of iron chelators in the treatment of Parkinson's disease and related neurological disorders. [Pharmacol Toxicol. 1997]
Review The potential role of iron chelators in the treatment of Parkinson's disease and related neurological disorders.
Gassen M, Youdim MB. Pharmacol Toxicol. 1997 Apr; 80(4):159-66.

See reviews... See all...

Cited by 4 PubMed Central articles

Manganese exposure induces microglia activation and dystrophy in the substantia nigra of non-human primates. [Neurotoxicology. 2011]
Manganese exposure induces microglia activation and dystrophy in the substantia nigra of non-human primates.
Verina T, Kiihl SF, Schneider JS, Guilarte TR. Neurotoxicology. 2011 Mar; 32(2):215-26. Epub 2010 Nov 26.
Chronic expression of H-ferritin in dopaminergic midbrain neurons results in an age-related expansion of the labile iron pool and subsequent neurodegeneration: implications for Parkinson's disease. [Brain Res. 2009]
Chronic expression of H-ferritin in dopaminergic midbrain neurons results in an age-related expansion of the labile iron pool and subsequent neurodegeneration: implications for Parkinson's disease.
Kaur D, Rajagopalan S, Andersen JK. Brain Res. 2009 Nov 10; 1297:17-22. Epub 2009 Aug 21.
Iron-enhanced paraquat-mediated dopaminergic cell death due to increased oxidative stress as a consequence of microglial activation. [Free Radic Biol Med. 2009]
Iron-enhanced paraquat-mediated dopaminergic cell death due to increased oxidative stress as a consequence of microglial activation.
Peng J, Stevenson FF, Oo ML, Andersen JK. Free Radic Biol Med. 2009 Jan 15; 46(2):312-20. Epub 2008 Nov 7.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Distribution of iron in different brain regions and subcellular compartments in ...
Distribution of iron in different brain regions and subcellular compartments in Parkinson's disease.
Ann Neurol. 1992 ;32 Suppl:S101-4.

PubMed
Crystal structure of human L-xylulose reductase holoenzyme: probing the role of ...
Crystal structure of human L-xylulose reductase holoenzyme: probing the role of Asn107 with site-directed mutagenesis.
Proteins. 2004 May 15 ;55(3):724-32.

PubMed
DRESS: a database of REfined solution NMR structures.
DRESS: a database of REfined solution NMR structures.
Proteins. 2004 May 15 ;55(3):483-6.

PubMed
New magnetic resonance techniques for evaluating cerebrovascular disease.
New magnetic resonance techniques for evaluating cerebrovascular disease.
Ann Neurol. 1992 Aug ;32(2):115-22.

PubMed
[Value of modern CT-techniques in the diagnosis of acute stroke].
[Value of modern CT-techniques in the diagnosis of acute stroke].
Radiologe. 2004 Apr ;44(4):380-8.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Distribution of iron in different brain regions and subcellular compartments in Parkinson's disease.

Source

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Medical

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Cited by 4 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information